Symbol
BBOT on Nasdaq
Investment type
Equity / Common Stock
Latest Disclosed Ownership
4.89M shares
Security Ownership
6.17%

Deerfield Management Company, L.P. ownership in BridgeBio Oncology Therapeutics, Inc. Common Stock (BBOT)

2025-08-18 - Deerfield Management Company, L.P. has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 4.89M shares of BridgeBio Oncology Therapeutics, Inc. Common Stock (BBOT). This represents 6.17% percent ownership of the company.